| |
Raltegravir (n=9) |
Atazanvir/r (n=8) |
p-value |
| Race |
|
|
|
| African American |
5 (56%) |
5 (63%) |
0.77* |
| Hispanic |
3 (33%) |
1 (13%) |
|
| Caucasian |
1 (11%) |
1 (25%) |
|
| Asian |
0 (0%) |
1 (13%) |
|
| Gender |
|
|
|
| Male |
6 (67%) |
6 (75%) |
1.00* |
| Female |
3 (33%) |
2 (25%) |
|
| Drug Screen/Drug Use |
|
|
|
| Positive |
5 (56%) |
2 (25%) |
0.33* |
| Age (yr) |
42.8 (13.2) |
43.8 (8.5) |
0.85 |
* Fisher’s exact test |
